Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Journal of Environmental Pathology, Toxicology and Oncology
Fator do impacto: 1.241 FI de cinco anos: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN Imprimir: 0731-8898
ISSN On-line: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.2013010051
pages 361-371

Tyrosine Kinase Inhibitor AG490 Inhibits the Proliferation and Migration and Disrupts Actin Organization of Cancer Cells

Mohammad Zahid Kamran
Gude Lab, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India
Prachi Patil
Gude Lab, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India
Kavita Shirsath
Gude Lab, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India
Rajiv P. Gude
Gude Lab, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India

RESUMO

Metastasis, a multistep process, is a major cause of mortality in cancer patients. Thus, it is hoped that inhibition of metastasis at any step, such as proliferation, migration, or invasion, using small-molecule inhibitors will reduce this mortality. Recent study suggests that the Janus kinase/signal transducer and activator of transcription 3 signal transduction pathway is a central pathway that regulates tumor progression and metastasis and can be blocked using tyrosine kinase inhibitors. In this study we used a synthetic tyrosine kinase inhibitor, AG490, to block the constitutive activation of the Janus kinase/signal transducer and activator of transcription 3 pathway in A549 lung carcinoma and A375 melanoma cell lines. Our results show that AG490 at subtoxic doses can effectively suppress tumor cell proliferation by limiting the expression of cyclin D1. Furthermore, AG490 is seen to induce apoptosis, inhibit cellular migration by disrupting actin organization, and suppress matrix metalloproteinase 2 activity. Taken together, these data demonstrate that AG490 can exert antimetastatic activity by inhibiting cellular proliferation, invasion, and migration.


Articles with similar content:

(−)-Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells
Journal of Environmental Pathology, Toxicology and Oncology, Vol.34, 2015, issue 1
Zhengshi Zhang, Yong Wang, Guoqing Tang, Hongbin Qian, Bin Chen, Ji Chen, Yong Chen, Xiang Chen
Cell survival and proliferation signaling pathways are downregulated by plasma-activated medium in glioblastoma brain tumor cells
Plasma Medicine, Vol.2, 2012, issue 4
Masaru Hori, Hiromasa Tanaka, Hiroaki Kajiyama, Shoichi Maruyama, Kenji Ishikawa, Masaaki Mizuno, Hiroyuki Kano, Fumi Utsumi, Kae Nakamura, Fumitaka Kikkawa
Regulating Expression of the Gene for Matrix Metalloproteinase-1 (Collagenase): Mechanisms that Control Enzyme Activity, Transcription, and mRNA Stability
Critical Reviews™ in Eukaryotic Gene Expression, Vol.6, 1996, issue 4
Matthew P. Vincenti, Constance E. Brinckerhoff, Lori A. White, Ulrike Benbow, Daniel J. Schroen
Increased Expression of COX-2 in the Development of Human Lung Cancers
Journal of Environmental Pathology, Toxicology and Oncology, Vol.21, 2002, issue 2
Ken-ichi Kozaki, Hiroyuki Achiwa, Toyoaki Hida, Takashi Takahashi, Yasushi Yatabe
Combined Gene Expression and DNA Occupancy Profiling as a Strategy to Identify Therapeutic Target(s) in t(8;21) Acute Myeloid Leukemia
Critical Reviews™ in Eukaryotic Gene Expression, Vol.23, 2013, issue 2
Luke F. Peterson, Miao-Chia Lo